“According to the Arab American Institute, only a quarter of Arab Americans practice Islam; a supermajority of them are actually Christian. Similarly, many Muslim Americans are South Asian, Black or some other non-Arab ethnicity (e.g., Iranian).”
…
“According to a poll from the Council on American-Islamic Relations, Muslims voted for Biden over Trump in 2020 69 percent to 17 percent (3 percent voted for a third-party candidate, and 11 percent refused to answer). And according to AP VoteCast, Muslims voted for Biden 64 percent to 35 percent. (The disagreement over Trump’s vote share really underscores how hard it is to survey such a small group!)
Meanwhile, Arab Americans told Zogby Analytics and the Arab American Institute in an October 2020 poll that they were planning to vote for Biden over Trump, 59 percent to 35 percent. Arab Americans who identified as Muslim in that poll supported Biden by a slightly wider margin, 60 percent to 30 percent. (Biden led more narrowly among Christian Arab Americans.)”
…
” There just aren’t a lot of Arab American and Muslim voters out there. The U.S. is only 0.7 percent Arab American and 1.3 percent Muslim. And most swing states don’t have significant Arab American or Muslim populations; even in Michigan, which has the largest such populations, they each make up less than 3 percent. And while the 100,000 “uncommitted” votes on Tuesday sounds like an impressive number, it is over 50,000 shy of Biden’s 2020 margin in the state (154,181 votes).
Muslim or Arab American voters could still tip the scales in Michigan … but only if the state is very close.”
“Only 3 percent of the people who have applied for green cards will receive one in FY 2024, as the backlog continues to grow and migrants continue to choose illegal migration pathways in large numbers. Today’s green card processing “reveals a legal immigration system that is utterly failing to direct aspiring immigrants to pursue the American dream in lawful and orderly ways,” wrote David J. Bier, associate director of immigration studies at the Cato Institute, in a report released last week.
About 1.1 million green cards may be issued in FY 2024, but there are currently 34.7 million pending applications. The backlog has its roots in the Immigration Act of 1924 and subsequent eligibility restrictions. While 98.1 percent of immigrant applicants were allowed to enter the country with permanent status from 1888 to 1921, just 16 percent of applicants were admitted in an average year once caps were imposed, per Bier. The rate fell to 3.8 percent in 2023.
Adding to the problem is the fact that the government has let 6.3 million green cards go to waste since 1921, failing to meet caps in large part due to processing delays.
Certain nationalities and green card categories experience more severe backlogs and selective processing. “Indians—who make up half the applicants in the employer-sponsored categories—must wait more than a century for a green card,” wrote Bier. People who try their luck at the green card lottery, which currently has about 22.2 million applicants, only have a 1 in 400 chance of getting a green card in a given year. Some who apply for family-based green cards “will face lifetime waits for many country-category combinations,” according to Bier.
By granting green cards to such a low percentage of applicants each year, the U.S. is leaving a lot of potential growth on the table. “Backlogged immigrants are likely to enter the United States and start working at higher rates than the general population, and they also appear to be more educated on average,” wrote Bier. And beyond being an important addition to the labor force, immigrants are helping to reduce the massive federal budget deficit and stave off population decline.
The Cato report suggests that Congress do away with “the unnecessarily onerous rules and arbitrary caps to approve current green card applicants.” After tackling the existing backlog, policy changes could be more modest, since “annual legal immigration would only need to increase more gradually to meet future demand.”
This report echoes the findings of June 2023 Cato Institute research, which found that “fewer than 1 percent of people who want to move permanently to the United States can do so legally.” A variety of factors keep people from qualifying for the existing green card categories, including low annual visa caps, a lack of U.S.-based sponsors (either employers or qualifying family members), narrow definitions of eligible nationalities, and cost.”
“For more than a year, the U.S. has experienced a shortage of Adderall, the medication used to treat attention-deficit/hyperactivity disorder (ADHD). Now, while continuing to deny its own role in the shortage, the federal government is making the problem worse by threatening manufacturers that could help ameliorate the crisis.
In October 2022, the Food and Drug Administration (FDA) announced a shortage of amphetamine mixed salts, Adderall’s primary ingredient. The announcement noted that manufacturers were “experiencing ongoing intermittent manufacturing delays” and it anticipated that the shortage could last until March 2023.
As Reason has reported since the FDA’s first announcement, the Drug Enforcement Administration (DEA) imposes production caps on Schedule I and II narcotics. Each year, drug manufacturers apply for a piece of the overall quotas. Even after a spike in demand during the COVID-19 pandemic, the DEA did not lift the production quotas on the ingredients used to make Adderall or its equivalents.”
…
“In April 2022, Ascent submitted its annual quota applications for 11 total drugs, but instead of a speedy approval, the company was subjected to a DEA audit.
Investigators pored over Ascent’s books and identified discrepancies that indicated sloppy record keeping. For its part, the company admitted to committing infractions, though the details seem needlessly petty: In one example, “orders struck from [DEA forms] must be crossed out with a line and the word cancel written next to them,” Walsh wrote. “Investigators found two instances in which Ascent employees had drawn the line but failed to write the word.”
The audit forced Ascent to shut down production at its facility on Long Island, near New York City; company officials told New York that this constituted 600 million annual doses that it is unable to produce. It began laying off workers after more than a year in regulatory limbo.
Ascent sued in September 2023, seeking an injunction “compelling DEA to respond, to Ascent’s applications for quotas.” The DEA quickly denied all of Ascent’s quota applications, saying that it “lacks confidence in the data provided by Ascent in its quota requests” but giving no specifics.”
…
“It’s entirely possible that Ascent did keep shoddy records, and perhaps it did misplace doses of drugs like opioids or stimulants that are ripe for abuse (allegations that the company denies). But the DEA’s policy of artificially constraining the supply of those drugs continues to harm those patients who actually need them.”